Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Florin Alexandru, Caruntu"'
Autor:
Pietro Lampertico, Elisabetta Degasperi, Lisa Sandmann, Heiner Wedemeyer, Cihan Yurdaydin, Dominique Roulot, Fabien Zoulim, Florin Alexandru Caruntu, Helenie Kefalakes, Julie Lucifora, Kosh Agarwal, Laurent Castera, Maria Buti, Mario Rizzetto, Markus Cornberg, Maura Dandri, Maurizia Brunetto, Nancy Reau, Robert Gish, Saeed Hamid, Soo Aleman, Stephan Urban, Tarik Asselah, Thomas Berg, Victor de Lédinghen
Publikováno v:
JHEP Reports, Vol 5, Iss 9, Pp 100818- (2023)
Summary: Chronic infection with hepatitis delta virus (HDV) affects between 12-20 million people worldwide and represents the most severe form of viral hepatitis, leading to accelerated liver disease progression, cirrhosis and its complications, such
Externí odkaz:
https://doaj.org/article/605a659388844615aca120322bfbfeb7
Autor:
Anika Wranke, Benjamin Heidrich, Stefanie Ernst, Beatriz Calle Serrano, Florin Alexandru Caruntu, Manuela Gabriela Curescu, Kendal Yalcin, Selim Gürel, Stefan Zeuzem, Andreas Erhardt, Stefan Lüth, George V Papatheodoridis, Birgit Bremer, Judith Stift, Jan Grabowski, Janina Kirschner, Kerstin Port, Markus Cornberg, Christine S Falk, Hans-Peter Dienes, Svenja Hardtke, Michael P Manns, Cihan Yurdaydin, Heiner Wedemeyer, HIDIT-2 Study Group
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101002 (2014)
Hepatitis delta frequently leads to liver cirrhosis and hepatic decompensation. As treatment options are limited, there is a need for biomarkers to determine disease activity and to predict the risk of disease progression. We hypothesized that anti-H
Externí odkaz:
https://doaj.org/article/37e9e3e2e8ec4160824f875cfb67f7bd
Autor:
Stefan Lüth, Selim Gürel, George V. Papatheodoridis, Birgit Bremer, Olympia E. Anastasiou, Manuela Curescu, Ulus Salih Akarca, Heiner Wedemeyer, Ramazan Idilman, Kendal Yalcin, Florin Alexandru Caruntu, Markus Cornberg, Cihan Yurdaydin, Andreas Erhardt, Stefan Zeuzem, Svenja Hardtke, Monica Radu, Michael P. Manns
Publikováno v:
Liver International
The role of low levels of HDV-RNA during and after interferon therapy of hepatitis D is unknown. We re-analysed HDV RNA in 372 samples collected in the HIDIT-2 trial (Wedemeyer et al, Lancet Infectious Diseases 2019) with the Robogene assay (RA; Jena
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c4f5f5f17edd90a7e9ac895c9a902b
https://pubmed.ncbi.nlm.nih.gov/33217778
https://pubmed.ncbi.nlm.nih.gov/33217778
Autor:
Heike Bantel, Cihan Yurdaydin, Florin Alexandru Caruntu, Stephanie Liebig, Monica Radu, Olympia E. Anastasiou, Michael P. Manns, Stefan Zeuzem, Svenja Hardtke, Birgit Bremer, Markus Cornberg, Heiner Wedemeyer, Kendal Yalcin, Benjamin Maasoumy, Manuela Curescu, Stefan Lüth, Andreas Erhardt, Ulus Salih Akarca, Selim Gürel, George V. Papatheodoridis
Publikováno v:
Journal of viral hepatitisREFERENCES. 28(2)
HBV-DNA levels are low or even undetectable in the majority HDV-infected patients. The impact of PEG-IFN alpha on HBV-DNA kinetics in HDV-infected patients has not been studied in detail. We analysed data of a prospective treatment trial where 120 HD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b4fc8787a2182cd8abdbc4a79c87d9c
https://pubmed.ncbi.nlm.nih.gov/33185325
https://pubmed.ncbi.nlm.nih.gov/33185325
Autor:
Scott Fung, Belinda Jump, Sang Hoon Ahn, William Guyer, Giovanni Battista Gaeta, Henry Lik-Yuen Chan, Magdy Elkhashab, Gerald Crans, Won Young Tak, Xiaoli Ma, Florin Alexandru Caruntu, Fehmi Tabak, Jörg Petersen, Wan-Long Chuang, Mani Subramanian, R. Mehta, Aric J. Hui, Patrick Marcellin, Alain Chan, Maria Buti, Robert Flisiak, George V. Papatheodoridis
Publikováno v:
Digestive Diseases and Sciences
Background and Aims Hepatitis B surface antigen (HBsAg) loss is the ideal clinical endpoint but is achieved rarely during oral antiviral treatment. A current unmet need in CHB management is achievement of HBsAg loss with a finite course of oral antiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fc17b99d3e8e998fd53f694c174d28
https://doi.org/10.1007/s10620-018-5251-9
https://doi.org/10.1007/s10620-018-5251-9
Autor:
Liana Gheorghe, Ciprian Brisc, Manuela Curescu, Ioan Sporea, Cristian Gheorghe, Iulia Simionov, Carol Stanciu, Roxana Sirli, Florin Alexandru Caruntu, Speranta Iacob, Victoria Aramă, Cristina Cijevschi, Anca Trifan, Razvan Iacob
Publikováno v:
Journal of Gastrointestinal and Liver Diseases. 26:275-281
Background & Aims: Ombitasvir/Paritaprevir/ritonavir/Dasabuvir (OBV/PTV/r+DSV) is one of the elective direct-acting antivirals (DAAs) recommended by international guidelines and the only one covered by the National Insurance System in Romania until N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a285190032882f3a785f4bcfc2902aa
https://doi.org/10.15403/jgld.2014.1121.263.iac
https://doi.org/10.15403/jgld.2014.1121.263.iac
Autor:
Valeriu Gheorghiță, Manuela Ioniță, Adelina Maria Radu, Florin Alexandru Caruntu, Laura Bălănescu
Publikováno v:
Journal of Contemporary Clinical Practice. 3:25-31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52760e50302b917b650710b02d90a36d
https://doi.org/10.18683/jccp.2017.1021
https://doi.org/10.18683/jccp.2017.1021
Autor:
Gheorghe Peltecu, Valeriu Gheorghita, Octavian Enciu, Bogdan Chirculescu, Florin Alexandru Caruntu, Monica Radu, Natalia Florina Buinoiu, Sabrina Ioana Enache, Alina Elena Barbu, Anca Maria Panaitescu
Publikováno v:
Indian Journal of Tuberculosis. 65:257-259
We present a case report of a young nulliparous woman that presented with progressive ascites, night sweats and weight loss. Clinical and para-clinical findings were not suggestive of pulmonary tuberculosis (TB) or other peritoneal conditions. A lapa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b54b41a83825147ee2ce99e49bede92
https://doi.org/10.1016/j.ijtb.2016.10.004
https://doi.org/10.1016/j.ijtb.2016.10.004
Autor:
Heiko von der Leyen, Kendal Yalcin, Ingmar Mederacke, Markus Cornberg, Ramazan Idilman, Stefan Lüth, Kerstin Port, Hans Peter Dienes, Judith Stift, Ulrike Wittkop, Cihan Yurdaydin, Manuela Curescu, Mustafa Kemal Çelen, Kristina Weber, Onur Keskin, Svenja Hardtke, Selim Gürel, Hidit-Ii study team, Monica Radu, Michael P. Manns, Andreas Erhardt, Heiner Wedemeyer, Benjamin Heidrich, Armin Koch, Ulus Salih Akarca, George V. Papatheodoridis, Florin Alexandru Caruntu, Stefan Zeuzem
Summary Background Hepatitis D is the most severe form of chronic viral hepatitis. Treatment guidelines recommend 1 year of peginterferon alfa, which is effective in 25–30% of patients only. Whether prolonged therapy with peginterferon alfa-2a for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9119c7b5a52a53c15a1bef95f500203a
http://hdl.handle.net/11452/29598
http://hdl.handle.net/11452/29598
Autor:
Gheorghiță, Florin Alexandru Caruntu
Publikováno v:
Journal of Gastrointestinal and Liver Diseases. 25:119-124
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7650127e1e71ab511eb2d293c65078e1
https://doi.org/10.15403/jgld.2014.1121.251.cld
https://doi.org/10.15403/jgld.2014.1121.251.cld